UAE says Sinopharm vaccine has 86% efficacy against Covid-19 | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 30, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 30, 2025
UAE says Sinopharm vaccine has 86% efficacy against Covid-19

Coronavirus chronicle

Reuters
09 December, 2020, 12:50 pm
Last modified: 09 December, 2020, 02:06 pm

Related News

  • UAE tops 50c in highest May temperature on record
  • What is Al-Ayyala dance that welcomed Trump in Abu Dhabi?
  • Pakistan's T20 cricket league moved to UAE over India conflict
  • World court dismisses Sudan's genocide case against UAE over alleged Darfur interference
  • UAE expedites visa issuance for Bangladeshis following talks

UAE says Sinopharm vaccine has 86% efficacy against Covid-19

The analysis also shows 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease

Reuters
09 December, 2020, 12:50 pm
Last modified: 09 December, 2020, 02:06 pm
Woman holds vials labelled "Covid-19 Coronavirus Vaccine" over dry ice in this illustration taken, 5 December, 2020/ Reuters
Woman holds vials labelled "Covid-19 Coronavirus Vaccine" over dry ice in this illustration taken, 5 December, 2020/ Reuters

An experimental coronavirus vaccine developed by China's Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm's China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows "99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease", the ministry said in a statement carried by the state news agency.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"The analysis shows no serious safety concerns," it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

It did not say what side effects or illnesses participants experienced or how many volunteers were given the vaccine and how many received a placebo.

CNBG could not be immediately reached for comment.

The vaccine, which uses an inactivated virus unable to replicate human cells to trigger immune responses, requires two doses, past trial data has showed.

The UAE trial is a partnership between Sinopharm's CNBG, Abu Dhabi-based artificial intelligence company Group 42 (G42) and the Abu Dhabi Department of Health.

Sinopharm and G42 have also expanded the trial to Egypt, Jordan and Bahrain.

Abu Dhabi, the UAE's capital, this week said it was seeking volunteers to take part in clinical trials of Russia's COVID-19 vaccine, known as Sputnik V.

The UAE, with a population of around 9 million, has recorded 178,837 infections and 596 deaths from the disease.

Top News / World+Biz

Sinopharm vaccine / UAE / covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Chief Adviser Muhammad Yunus meets Japanese Prime Minister Ishiba Shigeru in Japan on 30 May 2025. Photo: CA Office
    Bangladesh, Japan to sign EPA by year-end
  • File photo of BNP BNP Standing Committee Member Amir Khasru Mahmud Chowdhury
    Speaking about country’s issues in foreign trips won’t solve them: Khasru takes jibe at Yunus
  • Representational image. Photo: Collected
    'Heavy to very heavy' rainfall expected across country as land depression weakens further

MOST VIEWED

  • Photo: Courtesy
    New notes featuring historic, archaeological structures of Bangladesh to be circulated from 1 June
  • Two Memoranda of Understanding were signed at the seminar titled “Bangladesh Seminar on Human Resources,” in Tokyo on 29 May 2025. Photo: CA Press Wing
    Japan to recruit 100,000 Bangladeshi workers over next 5 years
  • BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
    BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
  • Representational Photo: Collected
    Country's all jewellery shops to remain indefinitely closed in protest of VP Reponul's arrest: Bajus
  • Khondoker Rashed Maqsood. File Photo: Collected
    Investors urge removal of BSEC chairman in meeting with CA’s special assistant, submit list of demands
  • Illustration: TBS
    Bangladesh repays $3.5b foreign debt in 10 months of FY25

Related News

  • UAE tops 50c in highest May temperature on record
  • What is Al-Ayyala dance that welcomed Trump in Abu Dhabi?
  • Pakistan's T20 cricket league moved to UAE over India conflict
  • World court dismisses Sudan's genocide case against UAE over alleged Darfur interference
  • UAE expedites visa issuance for Bangladeshis following talks

Features

Babar Ali, Ikramul Hasan Shakil, and Wasfia Nazreen are leading a bold resurgence in Bangladeshi mountaineering, scaling eight-thousanders like Everest, Annapurna I, and K2. Photos: Collected

Back to 8000 metres: How Bangladesh’s mountaineers emerged from a decade-long pause

3h | Panorama
Photos: Courtesy

Behind the looks: Bangladeshi designers shaping celebrity fashion

5h | Mode
Photo collage of the sailors and their catch. Photos: Shahid Sarkar

Between sky and sea: The thrilling life afloat on a fishing ship

10h | Features
For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

1d | The Big Picture

More Videos from TBS

Six Lakh Sacrificial Animals Ready in Sirajganj for Eid-ul-Adha

Six Lakh Sacrificial Animals Ready in Sirajganj for Eid-ul-Adha

40m | TBS Stories
Six MoUs signed during Chief Advisor's visit to Japan

Six MoUs signed during Chief Advisor's visit to Japan

4h | TBS Today
Record migrant deaths in 2024

Record migrant deaths in 2024

23h | Podcast
Govt likely to trim subsidies in new budget

Govt likely to trim subsidies in new budget

7h | TBS Insight
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net